5. SD of BP at baseline vs endpoint in trials with DBP entry criteria.
ARB | Placebo | ||
Weighted mean SD of SBP | At baseline (SD) | 13.5 (2.2) | 13.2 (1.5) |
At endpoint (SD) | 16.9 (3.8) | 16.0 (2.2) | |
t‐test | baseline vs endpoint | p = 0.03 | p = 0.03 |
Weighted mean SD of DBP | At baseline (SD) | 5.4 (1.6) | 4.9 (1.3) |
At endpoint (SD) | 8.1 (1.7) | 7.8 (1.6) | |
t‐test | baseline vs endpoint | p = 0.002 | p = 0.006 |